2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Tuesday, June 21, 2016

12:30pm-2:00pm: The Faroese Parkinson’s diseases research program-Multifactorial analyses of a complex syndrome

M.S. Petersen, S. Bech, E. Nosova, L.L. Farrell, I. Guella, D. Evans, B. Ritz, J. Aasly, M.J. Farrer (Tórshavn, Faroe Islands)

Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The French experience of liver transplantation for severe neurological forms of Wilson disease

A. Poujois, R. Sobesky, W. Meissner, E. de Medeiros, C. Vanlemmens, A.S. Brunet, E. Broussolle, J.C. Duclos-Vallée, F. Woimant (Paris, France)

Rare genetic and metabolic diseases · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The impact of levodopa and apomorphine on beta- and gamma-oscillations in cortico-basal ganglia circuits in experimental parkinsonism

J. Kühn, J.K. Haumesser, P.J. Magill, A.A. Kühn, V.V. Nikulin, C. van Riesen (Berlin, Germany)

Pathophysiology

12:30pm-2:00pm: The inflammatory burden of tic onset in a paediatric cohort: A preliminary study

A. Capuano, F. Nicita, M. Angeloni, F. Vigevano (Rome, Italy)

Tics/Stereotypies · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The interrater variability in clinical assessment of post-hypoxic myoclonus

J.C. van Zijl, M. Beudel, J.W.J. Elting, B.M. de Jong, J. van der Naalt, W.M. van den Bergh, A.O. Rossetti, M.A.J. Tijssen, J. Horn (Groningen, Netherlands)

Myoclonus · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The kinase Fyn mediates levodopa induced dyskinesias in Parkinson´s disease

J.E. Ferrario, S. Sanz-Blasco, M. Bordone, A. Damianich, A. Bernardi, G. Gomez, I. Taravini, E. Avale, O. Gershanik (Buenos Aires, Argentina)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The method of biofeedback training for the patients with Parkinson’s disease

I.S. Goursky, S.A. Likhachev, V.V. Vashchylin (Minsk, Belarus)

Technology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The phenotypic and genetic features of myoclonus-dystonia in six Saudi Arabian kindreds

S.A. Bohlega, A. Aldakheel, T. Alkhairallah, A. Alkhani, M. Almuhaizea, F. Alotaibi (Riyadh, Saudi Arabia)

Myoclonus · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The relevance of movement disorders gene panels in clinical practice: How many patients are we sorting out?

C. Barzaghi, C. Panteghini, M. Carecchio, A. Legati, V. Monti, C. Reale, F. Invernizzi, B. Garavaglia (Milan, Italy)

Genetics (NON-PD) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: The role of non-steroidal anti-inflammatory use in symptomatic and asymptomatic LRRK2 G2019S mutation carriers

K.A. Wyman-Chick, M.J. Barrett, S.A. Sperling, C.A. Manning (Charlottesville, VA, USA)

Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2